Board recommended final dividend for FY26
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Artemis Medicare Services reported strong FY26 results with standalone revenue from operations growing 16.1% to ₹1,06,049 Lacs from ₹91,326 Lacs in FY25. Net profit after tax increased 23.9% to ₹10,344 Lacs from ₹8,346 Lacs, with EPS rising to ₹6.55 from ₹5.42. The Board recommended a final dividend of ₹0.45 per equity share (45% on face value of ₹1) for FY26, subject to shareholder approval at the AGM. Statutory auditors T R Chadha & Co LLP issued an unmodified opinion on both standalone and consolidated financial results. Key board decisions included appointment of two new Independent Directors and re-appointment of statutory auditors for a second 5-year term.
The company delivered robust profit growth of ~24% YoY with strong cash generation from operations at ₹12,882 Lacs. The recommended dividend signals confidence in financial health, though the absolute amount is modest at ₹0.45 per share.